What changed in this filing

/stocks — the workspaceLOADING

Item 1. Financial Statements

2026-05-08 compared with 2025-11-07 · 124 added, 377 removed, 416 unchanged (55% of the section changed)

2 unchanged sentences

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)

($ in millions, except per common share amounts)

Three Months Ended Nine Months Ended

September 30, September 30,

2025 2024 2025 2024

Three Months Ended

Net sales $ 1,801.5 $ 1,604.7

3 unchanged sentences

General, administrative and other expenses 166.9 209.5

Loss on disposal of business — — 13.9 —

Equity income in earnings of unconsolidated affiliates ( 5.6 ) ( 4.8 )

2 unchanged sentences

Interest expense, net 60.0 61.3

Other expense (income), net 10.9 0.4 16.8 ( 0.5 )

Other (income) expense, net ( 10.2 ) 1.2

Total other expense, net 49.8 62.5

Income before income taxes 233.9 170.6 287.3 408.6

Income tax provision ( 56.2 ) ( 40.8 ) ( 42.9 ) ( 95.5 )

Net income before non-controlling interest 177.7 129.8 244.4 313.1

Net income (loss) attributable to non-controlling interest 0.3 ( 0.2 ) 1.1 0.7

Net income attributable to Somnigroup International Inc.

Income (loss) before income taxes 137.3 ( 49.3 )

Income tax (provision) benefit ( 33.4 ) 16.5

Net income (loss) before non-controlling interest 103.9 ( 32.8 )

Net (loss) income attributable to non-controlling interest ( 0.3 ) 0.3

Net income (loss) attributable to Somnigroup International Inc.

$ 104.2 $ ( 33.1 )

Earnings per common share:

Earnings (loss) per common share:

Basic $ 0.50 $ ( 0.17 )

6 unchanged sentences

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

($ in millions)

Three Months Ended Nine Months Ended

September 30, September 30,

2025 2024 2025 2024

Net income before non-controlling interest $ 177.7 $ 129.8 $ 244.4 $ 313.1

Three Months Ended

Net income (loss) before non-controlling interest $ 103.9 $ ( 32.8 )

Other comprehensive (loss) income, net of tax:

2 unchanged sentences

Other comprehensive (loss) income, net of tax ( 14.2 ) 30.3

Comprehensive income 163.8 166.8 329.6 326.8

Comprehensive income (loss) attributable to non-controlling interest 0.3 ( 0.2 ) 1.1 0.7

Comprehensive income attributable to Somnigroup International Inc.

Comprehensive income (loss) 89.7 ( 2.5 )

Comprehensive (loss) income attributable to non-controlling interest ( 0.3 ) 0.3

Comprehensive income (loss) attributable to Somnigroup International Inc.

$ 90.0 $ ( 2.8 )

4 unchanged sentences

($ in millions)

September 30, 2025 December 31, 2024

March 31, 2026 December 31, 2025

ASSETS (unaudited)

5 unchanged sentences

Total Current Assets 1,245.7 1,294.1

Restricted cash — 1,592.3

Property, plant and equipment, net 1,009.8 1,019.2

26 unchanged sentences

($ in millions) (unaudited)

Three Months Ended September 30, 2025

Somnigroup International Inc.

Stockholders' Equity

Non-controlling Interest Common Stock Treasury Stock Accumulated Other Comprehensive Loss Total Stockholders'

Shares Issued At Par Shares Issued At Cost Additional Paid in Capital Retained Earnings

Balance as of June 30, 2025

$ 8.9 283.8 $ 2.8 73.9 $ ( 1,665.5 ) $ 1,017.0 $ 3,574.5 $ ( 87.7 ) $ 2,841.1

Net income 177.4 177.4

Net income attributable to non-controlling interest 0.3 —

Dividend paid to non-controlling interest in subsidiary ( 0.3 ) —

Foreign currency adjustments, net of tax ( 13.9 ) ( 13.9 )

Dividends declared on common stock ($ 0.15 per share)

( 31.7 ) ( 31.7 )

Exercise of stock options — 0.7 ( 0.4 ) 0.3

Issuances of PRSUs and RSUs

— 0.1 ( 0.1 ) —

Treasury stock repurchased - PRSU/RSU releases — — —

Amortization of unearned stock-based compensation

Balance as of September 30, 2025

$ 8.9 283.8 $ 2.8 73.9 $ ( 1,664.7 ) $ 1,028.7 $ 3,720.2 $ ( 101.6 ) $ 2,985.4

Three Months Ended September 30, 2024

Three Months Ended March 31, 2026

Somnigroup International Inc.

2 unchanged sentences

Shares Issued At Par Shares Issued At Cost Additional Paid in Capital Retained Earnings

Balance as of June 30, 2024

Balance as of December 31, 2025

$ 8.9 283.8 $ 2.8 73.9 $ ( 1,664.3 ) $ 1,038.7 $ 3,829.2 $ ( 98.4 ) $ 3,108.0

2 unchanged sentences

Dividend paid to non-controlling interest in subsidiary ( 0.7 ) —

Adjustment to pension liability, net of tax — —

Foreign currency adjustments, net of tax ( 14.2 ) ( 14.2 )

1 unchanged sentence

( 36.0 ) ( 36.0 )

Exercise of stock options — 0.1 ( 0.1 ) —

Issuances of PRSUs and RSUs

2 unchanged sentences

Amortization of unearned stock-based compensation

Balance as of September 30, 2024

Balance as of March 31, 2026

$ 7.9 283.8 $ 2.8 73.5 $ ( 1,662.4 ) $ 1,022.2 $ 3,897.4 $ ( 112.6 ) $ 3,147.4

See accompanying Notes to Condensed Consolidated Financial Statements .

SOMNIGROUP INTERNATIONAL INC.

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (CONTINUED)

($ in millions)

Nine Months Ended September 30, 2025

Three Months Ended March 31, 2025

Somnigroup International Inc.

5 unchanged sentences

Net income ( 33.1 ) ( 33.1 )

Net income attributable to non-controlling interests 1.1 —

Net income attributable to non-controlling interest 0.3 —

Dividend paid to non-controlling interest in subsidiary ( 1.0 ) —

10 unchanged sentences

Amortization of unearned stock-based compensation

Balance as of September 30, 2025

$ 8.9 283.8 $ 2.8 73.9 $ ( 1,664.7 ) $ 1,028.7 $ 3,720.2 $ ( 101.6 ) $ 2,985.4

Nine Months Ended September 30, 2024

Somnigroup International Inc.

Stockholders' Equity

Non-controlling Interest Common Stock Treasury Stock Accumulated Other Comprehensive Loss Total Stockholders' Equity

Shares Issued At Par Shares Issued At Cost Additional Paid in Capital Retained Earnings

Balance as of December 31, 2023

$ 10.0 283.8 $ 2.8 111.5 $ ( 3,380.6 ) $ 558.7 $ 3,279.2 $ ( 136.7 ) $ 323.4

Net income 312.4 312.4

Net income attributable to non-controlling interests 0.7 —

Dividend paid to non-controlling interest in subsidiary ( 2.0 ) —

Adjustment to pension liability, net of tax ( 0.3 ) ( 0.3 )

Foreign currency adjustments, net of tax 14.0 14.0

Dividends declared on common stock ($ 0.39 per share)

( 68.8 ) ( 68.8 )

Exercise of stock options — 1.5 ( 1.2 ) 0.3

Issuances of PRSUs and RSUs

( 2.2 ) 92.1 ( 92.1 ) —

Treasury stock repurchased - PRSU/RSU releases 0.9 ( 43.8 ) ( 43.8 )

Amortization of unearned stock-based compensation

Balance as of September 30, 2024

Balance as of March 31, 2025

$ 8.6 283.8 $ 2.8 75.2 $ ( 1,675.1 ) $ 1,063.3 $ 3,507.2 $ ( 156.5 ) $ 2,741.7

4 unchanged sentences

($ in millions)

Nine Months Ended

September 30,

Three Months Ended

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income before non-controlling interest $ 244.4 $ 313.1

Adjustments to reconcile net income to net cash provided by operating activities:

Net income (loss) before non-controlling interest $ 103.9 $ ( 32.8 )

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

Depreciation and amortization 60.9 57.7

5 unchanged sentences

Equity income in earnings of unconsolidated affiliates ( 5.6 ) ( 4.8 )

Loss on disposal of business 13.9 —

Foreign currency adjustments and other 2.6 0.8

14 unchanged sentences

Repayments of finance lease obligations and other ( 7.4 ) ( 5.8 )

Net cash provided by (used in) financing activities 605.9 ( 435.7 )

Net cash (used in) provided by financing activities ( 204.7 ) 1,142.1

NET EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH ( 5.2 ) 11.8

(Decrease) increase in cash, cash equivalents and restricted cash ( 1,609.5 ) 29.3

Decrease in cash, cash equivalents and restricted cash ( 24.1 ) ( 1,598.6 )

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period 134.9 1,709.7

1 unchanged sentence

Supplemental cash flow information:

Cash paid during the period for:

Interest $ 197.1 $ 89.8

Income taxes, net of refunds $ 14.2 $ 80.1

Cash paid for interest $ 45.1 $ 52.2

Non-cash investing activities:

8 unchanged sentences

based, multinational company.

The term "Somnigroup" refers to Somnigroup International Inc.

The term "Somnigroup International" refers to Somnigroup International Inc.

only, and the term "Company" refers to Somnigroup International Inc.

and its consolidated subsidiaries.

Certain prior period amounts have been reclassified in the accompanying consolidated financial statements and notes thereto to conform to the current period presentation.

The Company designs, manufactures, distributes and retails bedding products, which include mattresses, foundations and adjustable bases, and other products, which include pillows and other accessories.

The Company also derives income from royalties by licensing Sealy® and Stearns & Foster® brands, technology and trademarks to other manufacturers.

The Company sells its products through two sales channels:

Wholesale and Direct.

On February 5, 2025, the Company completed the previously announced acquisition of Mattress Firm, the largest mattress specialty retailer in the U.S.

1 unchanged sentence

Mattress Firm's highly trained retail sales associates provide personalized service to help consumers choose the ideal bedding products across their robust assortment of market-leading brands.

The Company also derives income from royalties by licensing Sealy® and Stearns & Foster® brands, technology and trademarks to other manufacturers, as well as licensing the Mattress Firm® trademark to retail franchisees.

The Company sells its products through two sales channels:

Direct and Wholesale.

The Company has ownership interests in Asia-Pacific joint ventures to develop markets for Sealy® and Stearns & Foster® branded products and ownership in a United Kingdom joint venture to manufacture, market and distribute Sealy® and Stearns & Foster® branded products.

1 unchanged sentence

The equity method of accounting is used for these joint ventures, over which the Company has significant influence but does not have control, and consolidation is not otherwise required.

The Company's equity in the net income and losses of these investments is reported in equity income in earnings of unconsolidated affiliates in the accompanying Condensed Consolidated Statements of Income.

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X and include all of the information and disclosures required by generally accepted accounting principles in the United States ("GAAP") for interim financial reporting.

2 unchanged sentences

It is the opinion of management that all necessary adjustments for a fair presentation of the results of operations for the interim periods have been made and are of a recurring nature unless otherwise disclosed herein.

(b) Cash, Cash Equivalents and Restricted Cash.

Cash and cash equivalents consist of all highly liquid investments with initial maturities of three months or less.

The carrying value of cash and cash equivalents approximates fair value because of the short-term maturity of those instruments.

Restricted cash consists of proceeds from the Term B Loan which were funded into escrow as of December 31, 2024 and released upon the closing of the Mattress Firm Acquisition on February 5, 2025.

The carrying value of restricted cash approximates fair value because of the short-term maturity of those instruments.

Total cash, cash equivalents and restricted cash consisted of the following:

September 30, December 31,

(in millions) 2025 2024

Cash and cash equivalents $ 100.2 $ 117.4

Restricted cash — 1,592.3

Cash, cash equivalents and restricted cash $ 100.2 $ 1,709.7

SOMNIGROUP INTERNATIONAL INC.

AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

(b) Inventories .

Inventories are stated at the lower of cost or net realizable value, determined by either the first-in, first-out method or the weighted average cost method, depending on reportable segment , and consist of the following:

September 30, December 31,

March 31, December 31,

(in millions) 2026 2025

3 unchanged sentences

$ 631.0 $ 630.0

(d) Warranties .

The Company provides product warranties on both manufactured and sourced products and service warranties, which vary by segment, product and brand.

Estimates of warranty expenses are based primarily on historical claims experience, product testing and recent trends.

Estimated future obligations related to these products are charged to cost of sales in the period in which the related revenue is recognized.

The Company considers the impact of recoverable salvage value on warranty costs in determining its estimate of future warranty obligations.

The Company had the following activity for its accrued warranty expense from December 31, 2024 to September 30, 2025:

(in millions)

Balance as of December 31, 2024 $ 33.6

Liabilities assumed as a result of Mattress Firm Acquisition 25.3

Amounts accrued 16.6

Warranties charged to accrual ( 16.5 )

Balance as of September 30, 2025 $ 59.0

As of September 30, 2025 and December 31, 2024, $ 23.2 million and $ 15.3 million of accrued warranty expense is included as a component of accrued expenses and other current liabilities and $ 35.8 million and $ 18.3 million of accrued warranty expense is included in other non-current liabilities on the Company's accompanying Condensed Consolidated Balance Sheets, respectively.

(e) Allowance for Credit Losses .

The allowance for credit losses is the Company's best estimate of the amount of expected lifetime credit losses in the Company's accounts receivable.

The Company regularly reviews the adequacy of its allowance for credit losses.

The Company estimates losses over the contractual life using assumptions to capture the risk of loss, even if remote, based principally on how long a receivable has been outstanding.

As of September 30, 2025, the Company's accounts receivable were substantially current.

Account balances are charged off against the allowance for credit losses after all reasonable means of collection have been exhausted and the potential for recovery is considered remote.

Other factors considered include historical write-off experience, current economic conditions and also factors such as customer credit, past transaction history with the customer and changes in customer payment terms.

The allowance for credit losses is included in accounts receivable, net in the accompanying Condensed Consolidated Balance Sheets.

The Company had the following activity for its allowance for credit losses from December 31, 2024 to September 30, 2025:

(in millions)

Balance as of December 31, 2024

Amounts accrued 4.4

Write-offs charged against the allowance ( 42.2 )

Balance as of September 30, 2025

SOMNIGROUP INTERNATIONAL INC.

1 unchanged sentence

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

(f) Fair Value.

Financial instruments, although not recorded at fair value on a recurring basis, include cash and cash equivalents, accounts receivable, accounts payable and the Company's debt obligations.

3 unchanged sentences

The fair values of these material financial instruments are as follows:

(in millions) September 30, 2025 December 31, 2024

(in millions) March 31, 2026 December 31, 2025

2029 Senior Notes $ 770.4 $ 780.1

2031 Senior Notes $ 728.8 $ 748.8

(g) Cost of Sales .

Costs associated with net sales are recorded in cost of sales.

Cost of sales includes the costs of receiving, producing, inspecting, warehousing, insuring and shipping goods during the period, as well as depreciation and amortization of long-lived assets used in these processes.

Cost of sales also includes retail store occupancy costs such as rent, common area maintenance charges, real estate and other asset-based taxes, general maintenance, utilities, depreciation and certain insurance expenses.

The Company believes the classification of occupancy costs could vary widely throughout the industry.

Because of this, the Company's gross profit and gross profit as a percentage of net sales may not be comparable to others in the industry which may include occupancy costs in total operating expenses.

Additionally, cost of sales include royalties that the Company pays to other entities for the use of their names on products produced by the Company.

Royalty expense is not material to the Company's Condensed Consolidated Statements of Income.

Prior to the Mattress Firm Acquisition, the Company recorded retail store occupancy costs in selling and marketing expenses.

For the three and nine months ended September 30, 2024, retail store occupancy costs of $ 38.4 million and $ 113.3 million, respectively, were reclassified to cost of sales in the accompanying consolidated financial statements and notes thereto to conform to the current period presentation.

(h) Vendor Incentives.

The Company's Mattress Firm business segment earns various types of incentives from its suppliers related to purchase volume rebates, sales, reimbursements of certain sales and marketing expenses, long-term supply agreements and other ordinary course transactions, collectively referred to as vendor incentives.

Amounts earned for vendor incentives are recorded within accounts payable until realized and are not material to the Company's Condensed Consolidated Balance Sheets.

Vendor incentives are generally recorded as a reduction of inventory at the time of purchase and, subsequently, as a reduction to cost of sales when the product is sold.

Vendor incentives earned for long-term supply agreements are deferred and ratably recorded as a reduction to cost of sales over the life of the supply agreement.

Vendor incentives which represent the reimbursement of certain sales and marketing expenses for the vendor's products are recorded as a reduction of sales and marketing expenses.

Certain vendor incentives include product purchase estimates and assumptions which may result in subsequent period adjustments if actual results differ from the estimates and assumptions used at the time of recognition.

Vendor incentives earned for expense reimbursements also include estimates for sales and marketing expenses incurred at the time of recognition.

If vendor incentives exceed our sales and marketing expenses, the excess amount is recorded as a reduction to cost of sales.

The Company regularly reviews the adequacy of its estimates and assumptions used in the recognition of vendor incentives.

(d) Definitive Agreement with Leggett & Platt, Incorporated

On April 13, 2026, Somnigroup International and Leggett & Platt, Incorporated ("Leggett & Platt") entered into a definitive agreement (the "Merger Agreement") for a proposed business acquisition in which Somnigroup International, through a wholly-owned subsidiary, will acquire Leggett & Platt in an all-stock transaction (the "Transaction") valued at approximately $ 2.5 billion based on the closing price of Somnigroup International's common stock as of April 10, 2026 and inclusive of Leggett & Platt's existing indebtedness.

The Transaction is currently anticipated to close by year-end 2026, subject to the satisfaction of customary closing conditions, including approval by Leggett & Platt’s shareholders and receipt of applicable regulatory approvals.

The Transaction does not require Somnigroup International shareholder approval.

Following the close of the Transaction, Leggett & Platt is expected to operate as a separate business unit within Somnigroup and to maintain its offices in Carthage, Missouri.

SOMNIGROUP INTERNATIONAL INC.

2 unchanged sentences

(2) Net Sales

The following table presents the Company's disaggregated revenue by channel and geographical region, including a reconciliation of disaggregated revenue by segment, for the three months ended September 30, 2025 and 2024:

Three Months Ended September 30, 2025 Three Months Ended September 30, 2024

(in millions) Tempur Sealy North America Tempur Sealy International Mattress Firm Consolidated Tempur Sealy North America Tempur Sealy International Mattress Firm Consolidated

Wholesale $ 626.4 $ 112.9 $ — $ 739.3 $ 878.4 $ 103.4 $ — $ 981.8

Three Months Ended March 31, 2026 Three Months Ended March 31, 2025

(in millions) Mattress Firm Tempur Sealy North America Tempur Sealy International Consolidated Mattress Firm Tempur Sealy North America Tempur Sealy International Consolidated

Direct $ 885.9 $ 90.0 $ 220.4 $ 1,196.3 $ 593.7 $ 121.7 $ 190.6 $ 906.0

Net sales $ 736.1 $ 315.7 $ 1,070.8 $ 2,122.6 $ 1,015.3 $ 284.7 $ — $ 1,300.0

Tempur Sealy North America Tempur Sealy International Mattress Firm Consolidated Tempur Sealy North America Tempur Sealy International Mattress Firm Consolidated

Geographical Region

United States $ 660.6 $ — $ 1,070.8 $ 1,731.4 $ 935.3 $ — $ — $ 935.3

All other 75.5 315.7 — 391.2 80.0 284.7 — 364.7

Net sales $ 736.1 $ 315.7 $ 1,070.8 $ 2,122.6 $ 1,015.3 $ 284.7 $ — $ 1,300.0

Substantially all revenue is associated with bedding product sales.

Nine Months Ended September 30, 2025 Nine Months Ended September 30, 2024

(in millions) Tempur Sealy North America Tempur Sealy International Mattress Firm Consolidated Tempur Sealy North America Tempur Sealy International Mattress Firm Consolidated

Wholesale — 473.5 131.7 605.2 — 584.5 114.2 698.7

Direct 335.8 578.3 2,613.3 3,527.4 384.7 520.2 — 904.9

Net sales $ 885.9 $ 563.5 $ 352.1 $ 1,801.5 $ 593.7 $ 706.2 $ 304.8 $ 1,604.7

Tempur Sealy North America Tempur Sealy International Mattress Firm Consolidated Tempur Sealy North America Tempur Sealy International Mattress Firm Consolidated

Mattress Firm Tempur Sealy North America Tempur Sealy International Consolidated Mattress Firm Tempur Sealy North America Tempur Sealy International Consolidated

Geographical Region

10 unchanged sentences

The aggregate purchase price consisted of $ 3.1 billion in cash and approximately 34.2 million shares of the Company's common stock valued at $ 65.65 per share, which represents the simple average of the opening and closing price per share of the Company's common stock on the New York Stock Exchange (the "NYSE") on the trading day immediately prior to the date of acquisition, with the value of any fractional shares paid in cash.

In connection with the consummation of the merger, the Company borrowed $ 625.0 million of its Delayed Draw Term A Loan and $ 679.5 million of revolving commitments under its senior credit facility.

In addition, approximately $ 1,592.0 million of proceeds in respect of the Term B Loan were released from escrow.

The proceeds of this financing were collectively used to fund a portion of the cash consideration, the repayment of Mattress Firm's debt and the payment of certain fees and expenses related to the merger.

The Mattress Firm Acquisition enhances the Company's global omni-channel strategy and enables a seamless consumer experience, among other things.

1 unchanged sentence

The Company accounted for this transaction as a business combination in accordance with Accounting Standards Codification (“ASC”) 805, Business Combinations .

Mattress Firm's financial results for the periods from July 1, 2025 through September 30, 2025 and February 5, 2025 through September 30, 2025 (the "stub period") are included in the Company's Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2025, respectively.

Mattress Firm's financial results for the three months ended March 31, 2026 and the period of February 5, 2025 through March 31, 2025 (the "stub period") are included in the Company's Condensed Consolidated Financial Statements for the three months ended March 31, 2026 and March 31, 2025, respectively.

On May 1, 2025, the Company completed the previously announced divestiture of 73 Mattress Firm retail locations and the Company's Sleep Outfitters subsidiary, which includes 103 specialty mattress retail locations and seven distribution centers to MW SO Holdings Company, LLC ("Mattress Warehouse").

In the nine months ended September 30, 2025, the Company recorded a $ 13.9 million loss on disposal of business associated with the divestiture, net of proceeds of $ 9.0 million.

The Company does not expect the divestiture to have a material impact on its results of operations for the twelve months ended December 31, 2025.

The divestiture of Sleep Outfitters was not classified as assets and liabilities held for sale in the Company's Consolidated Balance Sheets as of December 31, 2024 due to the Mattress Firm Acquisition being contingent upon regulatory approval and the potential for the Company's plan of divestiture to change.

Preliminary Purchase Price Consideration

The preliminary purchase price of Mattress Firm as of February 5, 2025 consists of the following items:

Purchase Price Consideration

The final purchase price of Mattress Firm as of February 5, 2025 consists of the following items:

(in millions)

5 unchanged sentences

Net consideration transferred $ 5,141.4

(1) The stock consideration of 34.2 million shares of Somnigroup common stock represents a value of $ 65.65 per share, which is the simple average of the opening and closing price per share of the Company's common stock on the NYSE on the business day immediately prior to the date of acquisition.

(1) The stock consideration of 34.2 million shares of Somnigroup International common stock represents a value of $ 65.65 per share, which is the simple average of the opening and closing price per share of the Company's common stock on the NYSE on the business day immediately prior to the date of acquisition.

This amount includes stock consideration to Mattress Firm employees for equity awards converted into the right to receive merger consideration.

4 unchanged sentences

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

Preliminary Purchase Price Allocation

The preliminary allocation of the purchase price is based on the fair values of the assets acquired and liabilities assumed as of February 5, 2025.

The components of the preliminary purchase price allocation are as follows:

(in millions) Initial Allocation of Consideration Measurement

Adjustments Updated Preliminary Allocation

Final Purchase Price Allocation

The final allocation of the purchase price is based on the fair values of the assets acquired and liabilities assumed as of February 5, 2025.

The components of the final purchase price allocation are as follows:

(in millions) Final Allocation

Accounts receivable, net $ 21.5

7 unchanged sentences

Goodwill 3,493.9

Preliminary fair value of assets acquired $ 7,107.3 $ 116.6 $ 7,223.9

Fair value of assets acquired $ 7,387.7

Accounts payable ( 93.6 )

6 unchanged sentences

Long-term debt ( 11.0 )

Preliminary fair value of liabilities assumed ( 1,955.6 ) ( 127.1 ) ( 2,082.7 )

Fair value of liabilities assumed ( 2,246.3 )

Net consideration transferred 5,141.4

1 unchanged sentence

Total consideration transferred $ 5,408.4

(1) Represents valuation adjustments to trade name, operating leases and property and equipment during the measurement period.

(2) Represents the income tax effect for the preliminary purchase price allocation adjustments.

The fair values of assets acquired and liabilities assumed are preliminary and are based on the information that was available to management at the time the unaudited condensed consolidated financial statements were prepared.

The Company will finalize the valuation and complete the purchase price allocation as soon as practical, but no later than the measurement period of one year from the Mattress Firm Acquisition date.

The most significant open items include the estimation of certain long-lived assets and the accounting for income taxes as management is awaiting additional information to complete its assessment of these matters.

Measurement period adjustments will be recorded in the period in which they are determined, as if they had been completed at the acquisition date.

The finalization of the Company's purchase accounting assessment could result in changes in the valuation of assets acquired and liabilities assumed, which could be material.

The indefinite-lived intangible asset represents the Mattress Firm trade name.

2 unchanged sentences

Goodwill is calculated as the excess of the purchase price over the net assets acquired and primarily represents the future economic benefits expected from the expansion of consumer touchpoints, the assembled workforce acquired and operating efficiencies.

The goodwill is not deductible for income tax purposes and is included within the Mattress Firm business segment.

Due to carryover tax basis, approximately $ 164.6 million of the goodwill is deductible for income tax purposes and approximately $ 3,329.3 million is non-deductible for income tax purposes.

Combined total goodwill of $ 3,493.9 million is included within the Mattress Firm segment.

Transaction Costs

The Company incurred an immaterial amount of transaction costs related to the Mattress Firm Acquisition during the three months ended March 31, 2026 and $ 50.2 million in the three months ended March 31, 2025.

Transaction costs primarily included legal and professional fees associated with the Mattress Firm Acquisition.

SOMNIGROUP INTERNATIONAL INC.

1 unchanged sentence

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

Transaction Costs

The Company incurred an immaterial amount of transaction costs related to the Mattress Firm Acquisition during the three months ended September 30, 2025 and $ 13.7 million in the three months ended September 30, 2024.

The Company incurred $ 50.2 million of transaction costs related to the Mattress Firm Acquisition during the nine months ended September 30, 2025 compared to $ 35.8 million in the nine months ended September 30, 2024.

Transaction costs primarily included legal and professional fees associated with the Mattress Firm Acquisition.

Consolidated Results of Operations

The business acquired in the Mattress Firm Acquisition contributed revenue of $ 1,070.8 million and $ 2,613.3 million for the three and nine months ended September 30, 2025, respectively and contributed net income of $ 66.7 million and $ 119.8 million for the three and nine months ended September 30, 2025, respectively.

The business acquired in the Mattress Firm Acquisition contributed revenue of $ 885.9 million and $ 593.7 million for the three months ended March 31, 2026 and March 31, 2025, respectively and contributed net income of $ 32.4 million and $ 0.8 million for the three months ended March 31, 2026 and March 31, 2025, respectively.

Unaudited Pro Forma Financial Information

The following represents the unaudited consolidated pro forma financial information for the periods as if Mattress Firm had been included in the consolidated results of the Company since January 1, 2024.

The following represents the unaudited consolidated pro forma financial information for the period as if Mattress Firm had been included in the consolidated results of the Company since January 1, 2024.

Pro forma results do not include the effect of any future synergies anticipated to be achieved from the acquisition, and accordingly, are not necessarily indicative of the results that would have occurred if the acquisition had occurred on the date indicated or that may result in the future.

(unaudited) (unaudited)

Three Months Ended September 30, Nine Months Ended September 30,

Three Months Ended March 31,

(in millions) 2025

1 unchanged sentence

Pro forma net income $ ( 241.1 )

SOMNIGROUP INTERNATIONAL INC.

AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

The pro forma amounts have been calculated after applying the Company's accounting policies and by including the results of Mattress Firm, and adjusting the combined results to give effect to the following, as if the acquisition had been consummated on January 1, 2024, together with the consequential tax effects thereon:

(unaudited) Three months ended Nine months ended

(in millions) September 30, 2024 September 30, 2025 September 30, 2024

(unaudited) Three months ended

(in millions) March 31, 2025

Pro Forma Adjustments to Net Sales, as Reported:

1 unchanged sentence

Elimination of intercompany sales to Mattress Firm ( 78.0 )

( 244.7 ) ( 78.0 ) ( 698.9 )

Total adjustments to net sales $ 267.1

Pro Forma Adjustments to Net Income (Loss), as Reported:

Mattress Firm pre-acquisition earnings (loss) (1)

$ 10.7 $ ( 332.7 ) $ 62.0

Pro Forma Adjustments to Net Loss, as Reported:

Mattress Firm pre-acquisition loss (1)

Transaction costs (2)

— 50.2 ( 50.2 )

Intercompany profit elimination (3)

8.4 78.5 ( 64.9 )

Purchase price allocation adjustments (4)

0.9 16.7 ( 18.3 )

Interest expense adjustments (5)

( 18.1 ) ( 1.9 ) ( 52.9 )

Tax effect of pro forma adjustments (6)

2.2 ( 20.5 ) 29.6

Total adjustments to net income (loss) $ 4.1 $ ( 209.7 ) $ ( 94.7 )

(1) For the nine months ended September 30, 2025, Mattress Firm pre-acquisition loss included a one-time charge of $ 340.5 million related to stock-based compensation expense recognized when the Mattress Firm Acquisition became probable.

Total adjustments to net loss $ ( 208.0 )

(1) For the three months ended March 31, 2025, Mattress Firm pre-acquisition loss included a one-time charge of $ 340.5 million related to stock-based compensation expense recognized when the Mattress Firm Acquisition became probable.

(2) Represents $ 50.2 million of transaction costs for professional fees incurred by the Company in connection with the Mattress Firm Acquisition, which were reclassified to the prior year presented in accordance with ASC 805.

3 unchanged sentences

(6) Represents the income tax benefit (provision) for the above pro forma adjustments, which applies an estimated blended statutory income tax rate of 25.0 %.

(7) For the nine months ended September 30, 2024, intercompany sales to Mattress Firm of $ 698.9 million were comprised of $ 220.7 million, $ 233.5 million and $ 244.7 million of sales in the first, second and third quarters, respectively.

SOMNIGROUP INTERNATIONAL INC.

AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

The following summarizes changes to the Company's goodwill, by segment:

1 unchanged sentence

Balance as of December 31, 2025 $ 607.0 $ 495.0 $ 3,493.9 $ 4,595.9

Net goodwill resulting from acquisitions — — 3,324.7 3,324.7

Foreign currency translation and other ( 0.8 ) ( 8.2 ) — ( 9.0 )

Balance as of September 30, 2025 $ 606.0 $ 494.5 $ 3,324.7 $ 4,425.2

SOMNIGROUP INTERNATIONAL INC.

AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

Balance as of March 31, 2026 $ 606.2 $ 486.8 $ 3,493.9 $ 4,586.9

Debt for the Company consists of the following:

September 30, 2025 December 31, 2024

March 31, 2026 December 31, 2025

(in millions, except percentages) Amount Rate Amount Rate Maturity Date

14 unchanged sentences

Total long-term debt, net $ 4,436.4 $ 4,573.3

(1) Interest at SOFR index plus 10 basis points of credit spread adjustment, plus applicable margin of 1.625 % as of September 30, 2025.

(2) Interest at SOFR index plus 10 basis points of credit spread adjustment, plus applicable margin of 1.250 % as of December 31, 2024.

(3) Term B Interest at SOFR index plus applicable margin of 2.250 % as of September 30, 2025.

(4) Term B Interest at SOFR index plus applicable margin of 2.500 % as of December 31, 2024.

(1) Interest at SOFR index plus 10 basis points of credit spread adjustment, plus applicable margin of 1.375 % as of March 31, 2026 and December 31, 2025.

(2) Term B Interest at SOFR index plus applicable margin of 2.250 % as of March 31, 2026 and December 31, 2025.

(3) Interest at one month SOFR index plus 10 basis points of credit spread adjustment, plus 85 basis points.

(4) New finance lease obligations are a non-cash financing activity.

As of September 30, 2025, the Company was in compliance with all applicable debt covenants.

As of March 31, 2026, the Company was in compliance with all applicable debt covenants.

2023 Credit Agreement

On October 10, 2023, the Company entered into the 2023 Credit Agreement with a syndicate of banks.

The 2023 Credit Agreement provides for a $ 1.15 billion revolving credit facility, a $ 500.0 million term loan facility, and an incremental facility in an aggregate amount of up to the greater of $ 850.0 million and additional amounts subject to the conditions set forth in the 2023 Credit Agreement, plus the amount of certain prepayments, plus an additional unlimited amount subject to compliance with a maximum consolidated secured leverage ratio test.

The 2023 Credit Agreement has a $ 60.0 million sub-facility for the issuance of letters of credit.

On February 6, 2024, the Company and certain other parties thereto entered into an Amendment No.

1 ("Amendment No.

1") to the 2023 Credit Agreement which provided for a $ 625.0 million Delayed Draw Term A Loan and a $ 40.0 million increase in availability on the existing revolving loan.

This amendment was executed in connection with the Company's financing strategy for the Mattress Firm Acquisition.

On October 24, 2024, the Company and certain other parties thereto entered into an Amendment No.

2 ("Amendment No.

2") and an Amendment No.

3 ("Amendment No.

3") to the Company's 2023 Credit Agreement.

Amendment No.

2 extended the termination date for $ 605.0 million of the Delayed Draw Term A Loan commitments until October 24, 2025, among other changes.

Amendment No.

3 provided for an incremental Term B Loan in the aggregate principal amount of $ 1.6 billion.

The proceeds of the Term B Loan were funded into escrow, net of an original issue discount, on the closing of Amendment No.

On February 5, 2025, upon the consummation of the Mattress Firm Acquisition, the Company borrowed $ 625.0 million under our Delayed Draw Term A Loan and $ 679.5 million under the revolving credit facility.

In addition, approximately $ 1,592.0 million of proceeds in respect of the Term B Loan were released from escrow.

The proceeds of these

financings were collectively used to fund a portion of the cash consideration for the acquisition, the repayment of Mattress Firm's debt and the payment of certain fees and expenses related to the acquisition.

On June 24, 2025, the Company and certain other parties thereto entered into an Amendment No.

4 ("Amendment No.

4") to the Company's 2023 Credit Agreement.

Amendment No.

4 repriced the Company's existing Term B Loan due October 2031 by reducing the applicable margin on the Term B Loan by 0.25 % to (i) a base rate plus an applicable margin of 1.25 %, (ii) a Term SOFR rate plus an applicable margin of 2.25 % or (iii) a Daily Simple SOFR rate plus an applicable margin of 2.25 %, subject, in each case, to an additional 0.25 % rate reduction based on the Company's consolidated total leverage ratio.

In connection with the repricing, the Company prepaid $ 100.0 million of the outstanding Term B Loan (including accrued and unpaid interest in respect thereof) with cash proceeds from a borrowing under the revolving credit facility under the 2023 Credit Agreement.

The repriced Term B Loan is subject to a prepayment premium in connection with certain repricing transactions that may occur on or prior to the six-month anniversary of Amendment No.

On August 26, 2025, the Company prepaid $ 100.0 million of the outstanding Term B Loan (including accrued and unpaid interest in respect thereof).

The Company also prepaid $ 150.0 million of the outstanding Term B Loan on October 3, 2025.

These prepayments were funded with operating cash flows.

The Company had outstanding borrowings of $ 303.5 million under the revolving credit facility as of September 30, 2025.

Total availability under the revolving facility was $ 885.7 million, after a $ 0.8 million reduction for outstanding letters of credit, as of September 30, 2025.

The 2023 Credit Agreement provides for a $ 1,190.00 million revolving credit facility, a $ 500.0 million term loan facility, a $ 625.0 million Delayed Draw Term A Loan, a $ 1,600.0 million Term B Loan (which was initially placed in escrow, net of an original issue discount, and released upon the consummation of the Mattress Firm Acquisition) and an incremental facility in an aggregate amount up to the greater of $ 850.0 million and additional amounts subject to the conditions set forth in the 2023 Credit Agreement, plus the amount of certain prepayments, plus an additional unlimited amount subject to compliance with a maximum consolidated secured leverage ratio test.

The 2023 Credit Agreement also contains a $ 60.0 million sub-facility for the issuance of letters of credit.

The Company had outstanding borrowings of $ 426.5 million under the revolving credit facility as of March 31, 2026.

Total availability under the revolving facility was $ 762.7 million, after a $ 0.8 million reduction for outstanding letters of credit, as of March 31, 2026.

Securitized Debt

The Company and certain of its subsidiaries are party to a securitization transaction with respect to certain accounts receivable due to the Company and certain of its subsidiaries (as amended, the "Accounts Receivable Securitization").

As of September 30, 2025, there was no availability under the Accounts Receivable Securitization.

While subject to a $ 150.0 million overall limit, the availability of revolving loans varies over the course of the year based on the seasonality of the Company's accounts receivable.

Future Obligations

As of September 30, 2025, the scheduled maturities of long-term debt outstanding, excluding finance lease obligations, for each of the next five years and thereafter are as follows:

(in millions)

Remainder of 2025 $ 36.9

Thereafter 2,159.8

(1) Total future obligations excludes $ 34.7 million of outstanding letters of credit issued by various financial institutions, including $ 0.8 million associated with the 2023 Credit Facility.

SOMNIGROUP INTERNATIONAL INC.

AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

As of March 31, 2026, the Company had fully drawn down the Accounts Receivable Securitization with borrowings of $ 89.5 million.

Borrowings under this facility are classified as long-term debt within the Condensed Consolidated Balance Sheets at March 31, 2026, based on the Company's ability and intent to refinance on a long-term basis.

(6) Stockholders' Equity

(a) Treasury Stock.

As of September 30, 2025, the Company had approximately $ 774.5 million remaining under its share repurchase authorization.

The Company did not repurchase shares under the program during the three and nine months ended September 30, 2025 or 2024.

In addition, the Company acquired an insignificant amount of shares upon the exercise of stock options, the vesting of certain restricted stock units ("RSUs") and performance restricted stock units ("PRSUs"), which were withheld to satisfy tax withholding obligations during the three months ended September 30, 2025 and 2024, respectively.

The shares withheld were valued at the closing price of the stock on the New York Stock Exchange on the vesting date or first business day prior to vesting, resulting in an immaterial amount of treasury stock acquired during the three months ended September 30, 2025 and 2024, respectively.

The Company acquired 2.1 million and 0.9 million shares during the nine months ended September 30, 2025 and 2024, respectively, resulting in $ 132.4 million and $ 43.8 million in treasury stock acquired for the nine months ended September 30, 2025 and 2024, respectively.

As of March 31, 2026, the Company had approximately $ 774.5 million remaining under its share repurchase authorization.

The Company did not repurchase shares under the program during the three months ended March 31, 2026 or 2025.

The Company acquired 0.3 million and 0.7 million shares upon the vesting of certain restricted stock units ("RSUs") and performance restricted stock units ("PRSUs"), which were withheld to satisfy tax withholding obligations during each of the three months ended March 31, 2026 and 2025, respectively.

The shares withheld were valued at the closing price of the stock on the New York Stock Exchange on the vesting date or first business day prior to vesting, resulting in $ 26.2 million and $ 37.5 million in treasury stock acquired for the three months ended March 31, 2026 and 2025, respectively.

(b) Accumulated Other Comprehensive Loss ("AOCL").

AOCL consisted of the following:

Three Months Ended Nine Months Ended

September 30, September 30,

Three Months Ended

(in millions) 2026 2025

6 unchanged sentences

Balance at beginning of period $ 1.0 $ 0.4

Other comprehensive income (loss):

Other comprehensive income:

Net change from period revaluations (2)

— — 0.6 ( 0.3 )

Balance at end of period $ 1.0 $ 1.0

1 unchanged sentence

(2) In 2026 and 2025, there were no tax impacts related to pension adjustments.

SOMNIGROUP INTERNATIONAL INC.

AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

(7) Other Items

1 unchanged sentence

Accrued expenses and other current liabilities consisted of the following:

(in millions) September 30, 2025 December 31, 2024

(in millions) March 31, 2026 December 31, 2025

Wages and benefits $ 118.5 $ 130.6

5 unchanged sentences

$ 610.1 $ 636.5

SOMNIGROUP INTERNATIONAL INC.

AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

(8) Stock-Based Compensation

The Company's stock-based compensation expense for the three and nine months ended September 30, 2025 and 2024 included PRSUs, RSUs and non-qualified stock options.

The Company's stock-based compensation expense for the three months ended March 31, 2026 and 2025 included PRSUs, RSUs and non-qualified stock options.

A summary of the Company's stock-based compensation expense is presented in the following table:

Three Months Ended September 30, Nine Months Ended September 30,

Three Months Ended March 31,

(in millions) 2026 2025

6 unchanged sentences

During the first quarter of 2026, the Company granted PRSUs as a component of the long-term incentive plan ("2026 PRSUs").

The Company has recorded stock-based compensation expense related to the 2025 PRSUs during the three and nine months ended September 30, 2025, as it was probable that the Company would achieve the specified performance targets for the performance period.

The Company has recorded stock-based compensation expense related to the 2026 PRSUs during the three months ended March 31, 2026, as it was probable that the Company would achieve the specified performance targets for the performance period.

(9) Commitments and Contingencies

5 unchanged sentences

(10) Income Taxes

The Company's effective tax rates for the three months ended September 30, 2025 and 2024 were 24.0 % and 23.9 %, respectively.

The Company's effective tax rates for the nine months ended September 30, 2025 and 2024 were 14.9 % and 23.4 %, respectively.

The Company's effective tax rates for the three and nine months ended September 30, 2025 and 2024 differed from the U.S.

The Company's effective tax rates for the three months ended March 31, 2026 and 2025 were 24.3 % and 33.5 %, respectively.

The Company's effective tax rates for the three months ended March 31, 2026 and 2025 differed from the U.S.

federal statutory rate of 21.0% principally due to subpart F income (i.e., global intangible low-taxed income, or "GILTI," earned by the Company's foreign subsidiaries), foreign income tax rate differentials, state and local taxes, changes in the Company's uncertain tax positions, the excess tax benefit related to stock-based compensation and certain other permanent items.

The OECD (Organization for Economic Co-operation and Development) has proposed a global minimum effective tax of 15.0% on income arising in each jurisdiction ("Pillar 2") that has been agreed upon in principle by over 140 countries.

During 2024 and 2023, many countries took steps to incorporate Pillar 2 model rule concepts into their domestic laws.

Although the model rules provide a framework for applying the minimum tax, countries may enact Pillar 2 slightly differently than the model rules and on different timelines and may adjust domestic tax incentives in response to Pillar 2.

Accordingly, the Company is evaluating the potential consequences of Pillar 2 on its longer-term financial position.

In 2025, the Company does not expect Pillar 2 to have a material impact on its financial results.

On July 4, 2025, the Tax Act was signed into law.

While the Tax Act has multiple provisions that may impact the Company, guidance on the potentially relevant provisions has not been released by Congress or the Treasury department.

As such, it is unclear at this time what, if any, impact the Tax Act will have on the Company's income tax rate and associated financial results.

The Company will continue to evaluate the impact as further information becomes available.

SOMNIGROUP INTERNATIONAL INC.

3 unchanged sentences

The following table sets forth the components of the numerator and denominator for the computation of basic and diluted earnings per share for net income attributable to Somnigroup International Inc.:

Three Months Ended Nine Months Ended

September 30, September 30,

Three Months Ended

(in millions, except per common share amounts) 2026 2025

Net income attributable to Somnigroup International Inc.

Net income (loss) attributable to Somnigroup International Inc.

$ 104.2 $ ( 33.1 )

2 unchanged sentences

Denominator for diluted earnings per common share-adjusted weighted average shares 212.6 198.9

Basic earnings per common share $ 0.85 $ 0.75 $ 1.19 $ 1.80

Diluted earnings per common share $ 0.83 $ 0.73 $ 1.17 $ 1.75

Basic earnings (loss) per common share $ 0.50 $ ( 0.17 )

Diluted earnings (loss) per common share $ 0.49 $ ( 0.17 )

The Company excludes shares issuable upon exercise of certain outstanding stock options from the diluted earnings per common share computation because their exercise price was greater than the average market price of Somnigroup International Inc.'s common stock or they were otherwise anti-dilutive.

As a result, the Company excluded 1.2 million shares for the three months ended September 30, 2025, and 0.4 million shares for the nine months ended September 30, 2025 .

The Company did not exclude any shares for the three months ended September 30, 2024, and excluded an immaterial amount of shares for the nine months ended September 30, 2024.

As a result, the Company excluded 0.8 million shares for the three months ended March 31, 2026, and an immaterial amount of shares for the three months ended March 31, 2025.

Holders of non-vested stock-based compensation awards do not have voting rights but do participate in dividend equivalents distributed upon the award vesting.

1 unchanged sentence

The Company operates in three segments :

Tempur Sealy North America, Tempur Sealy International and Mattress Firm.

Mattress Firm, Tempur Sealy North America and Tempur Sealy International.

These segments are strategic business units that are managed separately.

The Mattress Firm segment consists of retail stores and distribution centers located in the U.S.

The Tempur Sealy North America segment consists of manufacturing, distribution and retail subsidiaries and licensees located in the U.S., Canada and Mexico (other than Mattress Firm retail and distribution locations).

The Tempur Sealy International segment consists of manufacturing, distribution and retail subsidiaries, joint ventures and licensees located in Europe, Asia-Pacific and Latin America (other than Mexico).

The Mattress Firm segment consists of retail stores and distribution centers located in the U.S.

The Company evaluates segment performance based on net sales, gross profit and operating income.

2 unchanged sentences

Inter-segment sales are made primarily at prices that approximate market-based selling prices.

SOMNIGROUP INTERNATIONAL INC.

AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

The following table summarizes total assets by segment:

(in millions) September 30, 2025 December 31, 2024

(in millions) March 31, 2026 December 31, 2025

Mattress Firm $ 8,021.6 $ 7,929.7

Tempur Sealy North America 5,885.1 5,717.9

Tempur Sealy International 1,569.6 1,542.3

Mattress Firm 7,769.4 —

Corporate 2,740.9 2,588.7

1 unchanged sentence

Total assets $ 11,539.6 $ 11,600.7

SOMNIGROUP INTERNATIONAL INC.

AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

The following table summarizes property, plant and equipment, net, by segment:

(in millions) September 30, 2025 December 31, 2024

(in millions) March 31, 2026 December 31, 2025

Mattress Firm $ 283.3 $ 270.7

Tempur Sealy North America 590.4 609.9

Tempur Sealy International 106.2 110.8

Mattress Firm 262.7 —

Corporate 29.9 27.8

1 unchanged sentence

The following table summarizes operating lease right-of-use assets by segment:

(in millions) September 30, 2025 December 31, 2024

(in millions) March 31, 2026 December 31, 2025

Mattress Firm $ 1,357.3 $ 1,344.9

Tempur Sealy North America 299.3 315.2

Tempur Sealy International 217.3 215.9

Mattress Firm 1,345.4 —

Corporate 2.5 2.8

Total operating lease right-of-use assets $ 1,876.4 $ 1,878.8

SOMNIGROUP INTERNATIONAL INC.

AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

The following table summarizes segment information for the three months ended September 30, 2025:

(in millions) Tempur Sealy North America Tempur Sealy International Mattress Firm Corporate Eliminations Consolidated

Net sales $ 736.1 $ 315.7 $ 1,070.8 $ — $ — $ 2,122.6

Inter-segment sales 314.0 0.1 — — ( 314.1 ) —

Total net sales and inter-segment sales $ 1,050.1 $ 315.8 $ 1,070.8 $ — $ ( 314.1 ) $ 2,122.6

Inter-segment royalty expense (income) 9.6 ( 9.6 ) — — — —

Gross profit 429.6 155.1 368.1 — — 952.8

Advertising expense 111.0 21.8 59.2 — — 192.0

Other selling and marketing expense 62.6 50.5 170.7 5.0 — 288.8

General, administrative and other expenses 41.6 28.9 57.0 32.9 — 160.4

Equity income in earnings of unconsolidated affiliates — ( 3.1 ) — — — ( 3.1 )

Operating income (loss) $ 214.4 $ 57.0 $ 81.2 $ ( 37.9 ) $ — $ 314.7

Interest expense, net 69.9

Other expense, net 10.9

Income before income taxes $ 233.9

Depreciation and amortization (1)

$ 30.0 $ 7.9 $ 23.1 $ 15.0 $ — $ 76.0

Capital expenditures 7.1 15.2 25.1 0.5 — 47.9

(1) Depreciation and amortization includes stock-based compensation amortization expense.

SOMNIGROUP INTERNATIONAL INC.

AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

The following table summarizes segment information for the three months ended September 30, 2024:

(in millions) Tempur Sealy North America Tempur Sealy International Corporate Eliminations Consolidated

The following table summarizes segment information for the three months ended March 31, 2026:

(in millions) Mattress Firm Tempur Sealy North America Tempur Sealy International Corporate Eliminations Consolidated

Net sales $ 885.9 $ 563.5 $ 352.1 $ — $ — $ 1,801.5

18 unchanged sentences

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

The following table summarizes segment information for the nine months ended September 30, 2025:

(in millions) Tempur Sealy North America Tempur Sealy International Mattress Firm Corporate Eliminations Consolidated

The following table summarizes segment information for the three months ended March 31, 2025:

(in millions) Mattress Firm Tempur Sealy North America Tempur Sealy International Corporate Eliminations Consolidated

Net sales $ 593.7 $ 706.2 $ 304.8 $ — $ — $ 1,604.7

6 unchanged sentences

General, administrative and other expenses 49.3 48.1 30.7 81.4 — 209.5

Loss on disposal of business 9.8 — 4.1 — — 13.9

Equity income in earnings of unconsolidated affiliates — — ( 4.8 ) — — ( 4.8 )

2 unchanged sentences

Other expense, net 1.2

Income before income taxes $ 287.3

Depreciation and amortization (1)

$ 91.0 $ 23.0 $ 57.7 $ 39.0 $ — $ 210.7

Capital expenditures 18.4 29.2 57.9 3.1 — 108.6

(1) Depreciation and amortization includes stock-based compensation amortization expense.

SOMNIGROUP INTERNATIONAL INC.

AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (unaudited) (continued)

The following table summarizes segment information for the nine months ended September 30, 2024:

(in millions) Tempur Sealy North America Tempur Sealy International Corporate Eliminations Consolidated

Net sales $ 2,894.8 $ 828.2 $ — $ — $ 3,723.0

Inter-segment sales 0.5 0.1 — ( 0.6 ) —

Total net sales and inter-segment sales 2,895.3 828.3 — ( 0.6 ) 3,723.0

Inter-segment royalty expense (income) 26.0 ( 26.0 ) — — —

Gross profit 1,141.0 402.4 — — 1,543.4

Advertising expense 281.1 65.5 — — 346.6

Other selling and marketing expense 205.4 135.8 12.1 — 353.3

General, administrative and other expenses 146.4 83.3 117.7 — 347.4

Equity income in earnings of unconsolidated affiliates — ( 10.5 ) — — ( 10.5 )

Operating income (loss) $ 508.1 $ 128.3 $ ( 129.8 ) $ — $ 506.6

Interest expense, net 98.5

Other income, net ( 0.5 )

Income before income taxes $ 408.6

Loss before income taxes $ ( 49.3 )

Depreciation and amortization (1)

4 unchanged sentences

(in millions)

September 30, 2025 December 31, 2024

March 31, 2026 December 31, 2025

United States

4 unchanged sentences

The following table summarizes operating lease right-of-use assets by geographic region:

(in millions) September 30, 2025 December 31, 2024

(in millions) March 31, 2026 December 31, 2025

United States $ 1,649.8 $ 1,653.1

2 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1. Financial Statements